TickerGuard
Buy Day today: Neutral (54) Mixed market breadth · no major macro event
COAG

Hemab Therapeutics Holdings, Inc.

Healthcare · Biotechnology

32.60$ -1.6% vs. previous close Closing price · As of: Sep 29, 2026

Statements

Balance Sheet

All figures as a percentage of total assets in the same period.

Tick rows to compare them in a chart (up to 4)

Balance Sheet COAG
Line item 2024 2025
100.0% 100.0%
96.8% 98.9%
77.3% 45.2%
– 95.2%
– 1.3%
219.7% 190.7%
6.9% 5.5%
– 0.3%
3.3% 2.9%
-119.7% -90.7%
-122.5% -93.4%
45.9% 14.1%

Data as of: September 29, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?